GPP
Great Point Partners’s Enanta Pharmaceuticals ENTA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-143,481
| Closed | -$10.2M | – | 35 |
|
|
2018
Q4 | $10.2M | Sell |
143,481
-66,919
| -32% | -$4.74M | 1.28% | 24 |
|
|
2018
Q3 | $18M | Buy |
+210,400
| New | +$18M | 2.8% | 18 |
|
|
2017
Q1 | – | Sell |
-828,253
| Closed | -$27.7M | – | 36 |
|
|
2016
Q4 | $27.7M | Buy |
828,253
+38,253
| +5% | +$1.28M | 5.7% | 7 |
|
|
2016
Q3 | $21M | Buy |
790,000
+251,976
| +47% | +$6.71M | 5.36% | 8 |
|
|
2016
Q2 | $11.9M | Buy |
+538,024
| New | +$11.9M | 3.4% | 11 |
|
|
2015
Q3 | – | Sell |
-35,000
| Closed | -$1.58M | – | 34 |
|
|
2015
Q2 | $1.58M | Sell |
35,000
-65,000
| -65% | -$2.93M | 0.61% | 28 |
|
|
2015
Q1 | $3.06M | Buy |
+100,000
| New | +$3.06M | 1.35% | 20 |
|